Lialda and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lialda (mesalamine) and Keppra (levetiracetam). Common drug interactions include pulmonary oedema among females and upper gastrointestinal haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Lialda and Keppra. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Lialda?

Lialda has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 10,199 Lialda users. Check the latest studies of Lialda.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.



On Jul, 10, 2026

13 people who take Lialda and Keppra together, and have interactions are studied.

Lialda and Keppra drug interactions.

What are the common drug interactions of Lialda and Keppra, by gender? *:

female:

  1. Pulmonary oedema (fluid accumulation in the lungs)
  2. Staphylococcal infection (an infection with staphylococcus bacteria)
  3. Weight decreased
  4. Fatigue (feeling of tiredness)
  5. Pneumonia
  6. Blood oestrogen decreased
  7. Body temperature decreased
  8. Diarrhoea
  9. Dizziness
  10. Drug effect decreased

male:

  1. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  2. Back pain
  3. Oropharyngeal pain
  4. Pyrexia (fever)
  5. Sepsis syndrome (a clinical condition of blood infection)
  6. Synovitis (inflammation of the synovial membrane)
  7. Cardiac valve disease (heart valve disease)
  8. Cough
  9. Diarrhoea
  10. Drug ineffective

What are the common drug interactions of Lialda and Keppra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Diarrhoea
  2. Fatigue (feeling of tiredness)
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Oral pain
  5. Stomatitis (inflammation of mucous membrane of mouth)

30-39:

n/a

40-49:

  1. Back pain
  2. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  3. Neck pain
  4. Occipital neuralgia (a condition characterized by chronic pain in the upper neck)

50-59:

  1. Intervertebral disc protrusion (spinal disc protrusion)
  2. Vertebral foraminal stenosis (narrowing of the intervertebral foramen)

60+:

  1. Pulmonary oedema (fluid accumulation in the lungs)
  2. Staphylococcal infection (an infection with staphylococcus bacteria)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Sepsis syndrome (a clinical condition of blood infection)
  5. Synovitis (inflammation of the synovial membrane)
  6. Weight decreased
  7. Pneumonia
  8. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  9. Cardiac valve disease (heart valve disease)
  10. Cough

What are the existing conditions these people have? *

  1. Bone Marrow Conditioning Regimen: 3 people, 23.08%
  2. Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 23.08%
  3. Pain: 2 people, 15.38%
  4. Muscle Spasms (muscle contraction): 2 people, 15.38%
  5. Cardiac Disorder: 2 people, 15.38%
  6. Stress And Anxiety: 1 person, 7.69%
  7. Depression: 1 person, 7.69%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 7.69%
  9. Brain Neoplasm Benign (non-cancerous tumour of brain): 1 person, 7.69%
  10. Colitis (inflammation of colon): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Lialda and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lialda and Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lialda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lialda and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mesalamine and levetiracetam (the active ingredients of Lialda and Keppra, respectively), and Lialda and Keppra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: